World Journal of Pharmaceutical Research (WJPR) has indexed with various reputed international bodies like : Index Copernicus , Google Scholar , EBSCO Publishing Inc (Academic Search Complete), USA , Indian Science Publications , Urlich's Periodicals Directory, Proquest, UK , NewJour-Georgetown University Library, USA , SOCOLAR, China , eGranary Digital Library, USA , CAS (A Division of American Chemical Society) USA , Research Bible, Fuchu, Tokyo. JAPAN , Science Central, USA , Kaohsiung Medical University Library, CHINA , VIKAS PSOAR (Pharmaceutical Sciences Open Access Resources) , Scopus ((Elsevier Products in process) , EMBASE (Elsevier Products, in process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , Thomson Reuters, USA (in process) , Genamics JournalSeek (In Process) , Hinari Research , Geneva Foundation for Medical Education and Research, Switzerland (In Process) , Lupton Library, (In Process) , Polish Scholarly Bibliography , Virtual Library Pharmacy, Medicine and Health, Biosciences , UDLedge Science Citation Index , Global Impact Factor (0.652) , International Impact Factor Services , Directory of Research Journal Indexing (DRJI) , Universal Impact Factor (0.9861) , International Scientific Indexing, UAE , SJIF Impact Factor (5.045) , Scholar Steer, (Under Process) , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , InfoBase Index (In Process) , Scholar Article Impact Factor, SAIF , CiteFactor , Journal Index (JI, Under Process) , Indian citation Index (ICI) , Indian Citation Index (ICI) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Eurasian Scientific Journals Index (ESJI) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Journalseek Database , Pubmed Database [NLM ID:101644668] (Under Process) , IP Indexing (Under Process) , EBSCO, USA , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) ,

WJPR

World Journal of Pharmaceutical Research

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical and Medical Research and Technology

Impact Factor : 8.084

ICV : 90.8

WJPR Citation

	All	Since 2011
Citation	2903	2393
h-index	27	24
i10-index	68	60

Login

Best Paper Awards

World Journal of Pharmaceutical Research (WJPR) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.

Best Paper Award :
Dr. Muhammad Baqir MR Fakhrildin
Download Article: Click Here

Search

Track Your Article

Track Your Article

Abstract

CRITICAL APPRAISAL OF DRUG PROMOTIONAL ADVERTISEMENTS OF DIFFERENT PHARMACEUTICAL COMPANIES AS PER WHO GUIDELINES

Virendra Kushwaha*, Pooja Agrawal, Pushpendra Pushkar, A. K. Singh and S. K. Barman

ABSTRACT

Objective: With the competition between pharmaceutical companies and a vast amount of increment in drug promotional spending, unethical practices are not uncommon. The objective of this study was to critically analyse the data that is presented to the practitioners on drug promotional advertisements (DPAs). Methods: An observational study to critically assess DPAs was carried out in the Department of Pharmacology & Therapeutics, GSVM Medical College, Kanpur, U.P. The DPAs were collected randomly from the websites of respective pharmaceutical companies. Each DPA was analysed as per the WHO established ethical criteria for medicinal drug promotional advertisements. Results: A total of 250 DPAs were collected and analysed. Most of the DPAs were for antimicrobial drugs (18%) and except for the brand name, none information was contained in all DPAs. Most of the DPAs contained information such as the name(s) and the content of the active ingredient(s), dosage form, and approved therapeutic uses but only a few of all DPAs (3.6%) had safety information such as the side-effects, major adverse drug reactions, precautions, contraindications, warnings, and major interaction and none had information regarding the name of other ingredients known to cause problems. The reference to scientific literature was written in only 14% of DPAs. DPAs provide only a maximum of 5 or 6 types of information out of 11 as per the WHO established ethical criteria. Conclusions: The pharmaceutical companies hide the safety information in most of the DPAs and do not support their claims with appropriate references. For safe and rational prescribing practitioners should also consider gathering the information regarding the drug or the brand from medium other than the DPAs of the respective pharmaceutical companies.

Keywords: WHO, Ethical drug promotion, drug advertisements, drug brochures, drug promotional literature.

[Full Text Article]